SwePub
Sök i LIBRIS databas

  Extended search

onr:"swepub:oai:gup.ub.gu.se/132557"
 

Search: onr:"swepub:oai:gup.ub.gu.se/132557" > X-linked thrombocyt...

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist
  • Albert, Michael H (author)

X-linked thrombocytopenia (XLT) due to WAS mutations: clinical characteristics, long-term outcome, and treatment options.

  • Article/chapterEnglish2010

Publisher, publication year, extent ...

  • American Society of Hematology,2010

Numbers

  • LIBRIS-ID:oai:gup.ub.gu.se/132557
  • https://gup.ub.gu.se/publication/132557URI
  • https://doi.org/10.1182/blood-2009-09-239087DOI

Supplementary language notes

  • Language:English

Part of subdatabase

Classification

  • Subject category:ref swepub-contenttype
  • Subject category:art swepub-publicationtype

Notes

  • A large proportion of patients with mutations in the Wiskott-Aldrich syndrome (WAS) protein gene exhibit the milder phenotype termed X-linked thrombocytopenia (XLT). Whereas stem cell transplantation at an early age is the treatment of choice for patients with WAS, therapeutic options for patients with XLT are controversial. In a retrospective multicenter study we defined the clinical phenotype of XLT and determined the probability of severe disease-related complications in patients older than 2 years with documented WAS gene mutations and mild-to-moderate eczema or mild, infrequent infections. Enrolled were 173 patients (median age, 11.5 years) from 12 countries spanning 2830 patient-years. Serious bleeding episodes occurred in 13.9%, life-threatening infections in 6.9%, autoimmunity in 12.1%, and malignancy in 5.2% of patients. Overall and event-free survival probabilities were not significantly influenced by the type of mutation or intravenous immunoglobulin or antibiotic prophylaxis. Splenectomy resulted in increased risk of severe infections. This analysis of the clinical outcome and molecular basis of patients with XLT shows excellent long-term survival but also a high probability of severe disease-related complications. These observations will allow better decision making when considering treatment options for individual patients with XLT.

Subject headings and genre

Added entries (persons, corporate bodies, meetings, titles ...)

  • Bittner, Tanja C (author)
  • Nonoyama, Shigeaki (author)
  • Notarangelo, Lucia Dora (author)
  • Burns, Siobhan (author)
  • Imai, Kohsuke (author)
  • Espanol, Teresa (author)
  • Fasth, Anders,1945Gothenburg University,Göteborgs universitet,Institutionen för kliniska vetenskaper, Avdelningen för pediatrik,Institute of Clinical Sciences, Department of Pediatrics(Swepub:gu)xfasan (author)
  • Pellier, Isabelle (author)
  • Strauss, Gabriele (author)
  • Morio, Tomohiro (author)
  • Gathmann, Benjamin (author)
  • Noordzij, Jeroen G (author)
  • Fillat, Cristina (author)
  • Hoenig, Manfred (author)
  • Nathrath, Michaela (author)
  • Meindl, Alfons (author)
  • Pagel, Philipp (author)
  • Wintergerst, Uwe (author)
  • Fischer, Alain (author)
  • Thrasher, Adrian J (author)
  • Belohradsky, Bernd H (author)
  • Ochs, Hans D (author)
  • Göteborgs universitetInstitutionen för kliniska vetenskaper, Avdelningen för pediatrik (creator_code:org_t)

Related titles

  • In:Blood: American Society of Hematology115:16, s. 3231-32381528-00200006-4971

Internet link

Find in a library

  • Blood (Search for host publication in LIBRIS)

To the university's database

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view